Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1569-1574

  Calabresi, Laura ^a   Baldassarre, Damiano ^a,b   Simonelli, Sara ^a   Gomaraschi, Monica ^a   Amato, Mauro ^b   Castelnuovo, Samuela ^a   Frigerio, Beatrice ^b   Ravani, Alessio ^b   Sansaro, Daniela ^b   Kauhanen, Jussi ^c   Rauramaa, Rainer ^c   De Faire, Ulf ^d   Hamsten, Anders ^e   Smit, Andries J ^f   Mannarino, Elmo ^g   Humphries, Steve E ^h   Giral, Philippe ⁱ   Veglia, Fabrizio ^b   Sirtori, Cesare R ^a   Franceschini, Guido ^a   Tremoli, Elena ^a,b   more..

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF PERUGIA   (Italy)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Cardiovascular disease; High density lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 79960678849     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P014977     Document Type: Article

References (24)

1. Jonas, A. 2000. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta. 1529: 245-256.
2. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-162.
3. Tanigawa, H., J. T. Billheimer, J. I. Tohyama, I. V. Fuki, D. S. Ng, G. H. Rothblat, and D. J. Rader. 2009. Lecithin:cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo. Circulation. 120: 160-169.
4. Calabresi, L., E. Favari, E. Moleri, M. P. Adorni, M. Pedrelli, S. Costa, W. Jessup, I. C. Gelissen, P. T. Kovanen, F. Bernini, et al. 2009. Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis. 204: 141-146.
5. Schwartz, C. C., Z. R. Vlahcevic, M. Berman, J. G. Meadows, R. M. Nisman, and L. Swell. 1982. Central role of high density lipoprotein in plasma free cholesterol metabolism. J. Clin. Invest. 70: 105-116.
6. Schwartz, C. C., J. M. VandenBroek, and P. S. Cooper. 2004. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J. Lipid Res. 45: 1594-1607.
7. Rousset, X., R. Shamburek, B. Vaisman, M. Amar, and A. T. Remaley. 2011. Lecithin cholesterol acyltransferase: an anti- or proatherogenic factor? Curr. Atheroscler. Rep. 13: 249-256.
8. Solajic Bozicevic, N., A. Stavljenic, and M. Sesto. 1991. Lecithin:cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease. Artery. 18: 326-340.
9. Solajic-Bozicevic, N., A. Stavljenic-Rukavina, and M. Sesto. 1994. Lecithin-cholesterol acryltransferase activity in patients with coronary artery disease examined by coronary angiography. Clin. Investig. 72: 951-956.
10. Wells, I. C., G. Peitzmeier, and J. K. Vincent. 1986. Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis. Exp. Mol. Pathol. 45: 303-310.
11. Dullaart, R. P., F. Perton, M. M. van der Klauw, H. L. Hillege, and W. J. Sluiter. 2010. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol. Atherosclerosis. 208: 537-542.
12. Holleboom, A. G., J. A. Kuivenhoven, M. Vergeer, G. K. Hovingh, J. N. van Miert, N. J. Wareham, J. J. Kastelein, K. T. Khaw, and S. M. Boekholdt. 2010. Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study. J. Lipid Res. 51: 416-421.
13. Stein, J. H., C. E. Korcarz, R. T. Hurst, E. Lonn, C. B. Kendall, E. R. Mohler, S. S. Najjar, C. M. Rembold, and W. S. Post. 2008. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J. Am. Soc. Echocardiogr. 21: 93-111.
14. Baldassarre, D., M. Amato, L. Pustina, E. Tremoli, C. R. Sirtori, L. Calabresi, and G. Franceschini. 2002. Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscler. Thromb. Vasc. Biol. 22: 317-322.
15. Junyent, M., M. Cofan, I. Nunez, R. Gilabert, D. Zambon, and E. Ros. 2006. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 26: 1107-1113.
16. Amato, M., P. Montorsi, A. Ravani, E. Oldani, S. Galli, P. M. Ravagnani, E. Tremoli, and D. Baldassarre. 2007. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur. Heart J. 28: 2094-2101.
17. O'Leary, D. H., J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson, Jr. 1999. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340: 14-22.
18. Baldassarre, D., K. Nyyssonen, R. Rauramaa, U. de Faire, A. Hamsten, A. J. Smit, E. Mannarino, S. E. Humphries, P. Giral, E. Grossi, et al. 2010. Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur. Heart J. 31: 614-622.
19. Murakami, T., S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini. 1995. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1819-1828.
20. Dullaart, R. P., F. Perton, W. J. Sluiter, V. R. De, and T. A. Van. 2008. Plasma lecithin:cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. J. Clin. Endocrinol. Metab. 93: 4860-4866.
21. Calabresi, L., D. Baldassarre, S. Castelnuovo, P. Conca, L. Bocchi, C. Candini, B. Frigerio, M. Amato, C. R. Sirtori, P. Alessandrini, et al. 2009. Functional lecithin:cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation. 120: 628-635.
22. Calabresi, L., L. Pisciotta, A. Costantin, I. Frigerio, I. Eberini, P. Alessandrini, M. Arca, G. B. Bon, G. Boscutti, G. Busnach, et al. 2005. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler. Thromb. Vasc. Biol. 25: 1972-1978.
23. Van Eck, M., I. S. Bos, W. E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E. S. Van Amersfoort, T. A. Christiansen-Weber, W. P. Fung-Leung, et al. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. USA. 99: 6298-6303.
24. de la Llera-Moya, M., D. Drazul-Schrader, B. F. Asztalos, M. Cuchel, D. J. Rader, and G. H. Rothblat. 2010. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler. Thromb. Vasc. Biol. 30: 796-801.